{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:18:19Z","timestamp":1766391499276,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.molimm.2025.08.024","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:37:30Z","timestamp":1757119050000},"page":"48-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["MAP30 inhibits proliferation and metastasis of bladder cancer by increasing EGR1 expression and promoting the transcriptional activation of DUSP1"],"prefix":"10.1016","volume":"187","author":[{"given":"Kaiyue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3821-4078","authenticated-orcid":false,"given":"Xiaozhou","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2025.08.024_bib1","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/s41598-023-29365-7","article-title":"Recombinant anti-HIV MAP30, a ribosome inactivating protein: against plant virus and bacteriophage","volume":"13","author":"Amirzadeh","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2025.08.024_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105157","article-title":"MAP30 protein from momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis","volume":"161","author":"Chan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.molimm.2025.08.024_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13205-016-0590-8","article-title":"Novel purification method and antibiotic activity of recombinant momordica charantia MAP30","volume":"7","author":"Chang","year":"2017","journal-title":"3 Biotech"},{"key":"10.1016\/j.molimm.2025.08.024_bib4","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.molimm.2025.08.024_bib5","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"10.1016\/j.molimm.2025.08.024_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12033-008-9034-y","article-title":"Effects of recombinant MAP30 on cell proliferation and apoptosis of human colorectal carcinoma LoVo cells","volume":"39","author":"Fan","year":"2008","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.molimm.2025.08.024_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.710689","article-title":"Siglec-15 promotes tumor progression in osteosarcoma via DUSP1\/MAPK pathway","volume":"11","author":"Fan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molimm.2025.08.024_bib8","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.3892\/mmr.2015.3176","article-title":"\u0391-MMC and MAP30, two ribosome-inactivating proteins extracted from momordica charantia, induce cell cycle arrest and apoptosis in A549 human lung carcinoma cells","volume":"11","author":"Fan","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.molimm.2025.08.024_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2012.05.005","article-title":"The MAP30 protein from bitter gourd (Momordica charantia) seeds promotes apoptosis in liver cancer cells in vitro and in vivo","volume":"324","author":"Fang","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molimm.2025.08.024_bib10","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12885-019-6014-5","article-title":"Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer","volume":"19","author":"Feng","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molimm.2025.08.024_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111180","article-title":"CXXC5 drove inflammation and ovarian cancer proliferation via transcriptional activation of ZNF143 and EGR1","volume":"119","author":"Geng","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.molimm.2025.08.024_bib12","first-page":"275","article-title":"Expression of momordica charantia MAP30 and its antitumor effect on bladder cancer cells","volume":"68","author":"Hlin","year":"2016","journal-title":"Minerva Urol. e Nefrol. = Ital. J. Urol. Nephrol."},{"key":"10.1016\/j.molimm.2025.08.024_bib13","first-page":"71","article-title":"Early growth Response-1 suppresses human fibrosarcoma cell invasion and angiogenesis","volume":"3","author":"Huang","year":"2006","journal-title":"Cancer Genom. Proteom."},{"key":"10.1016\/j.molimm.2025.08.024_bib14","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1271\/bbb.70103","article-title":"Induction of Egr-1 is associated with anti-metastatic and anti-invasive ability of beta-lapachone in human hepatocarcinoma cells","volume":"71","author":"Kim","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.molimm.2025.08.024_bib15","first-page":"653","article-title":"Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30","volume":"20","author":"Lee-Huang","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.molimm.2025.08.024_bib16","doi-asserted-by":"crossref","first-page":"634","DOI":"10.7150\/jca.81069","article-title":"A mechanism study of DUSP1 in inhibiting malignant progression of endometrial carcinoma by regulating ERK\/AP-1 axis and dephosphorylation of EPHA2","volume":"14","author":"Lei","year":"2023","journal-title":"J. Cancer"},{"key":"10.1016\/j.molimm.2025.08.024_bib17","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"key":"10.1016\/j.molimm.2025.08.024_bib18","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1038\/s41388-019-0873-8","article-title":"EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis","volume":"38","author":"Li","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2025.08.024_bib19","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.7150\/jca.95328","article-title":"EGR1 promotes Erastin-induced ferroptosis through activating Nrf2-HMOX1 signaling pathway in breast cancer cells","volume":"15","author":"Lin","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.molimm.2025.08.024_bib20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.clbc.2022.05.010","article-title":"FRZB is regulated by the transcription factor EGR1 and inhibits the growth and invasion of Triple-Negative breast cancer cells by regulating the JAK\/STAT3 pathway","volume":"22","author":"Liu","year":"2022","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.molimm.2025.08.024_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12922","article-title":"EGR1-mediated linc01503 promotes cell cycle progression and tumorigenesis in gastric cancer","volume":"54","author":"Ma","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.molimm.2025.08.024_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/onc.2010.449","article-title":"DUSP1\/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer","volume":"30","author":"Moncho-Amor","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2025.08.024_bib23","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.3892\/or.2016.4705","article-title":"MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells","volume":"35","author":"Qian","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.molimm.2025.08.024_bib24","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/cam4.772","article-title":"Role of DUSP1\/MKP1 in tumorigenesis, tumor progression and therapy","volume":"5","author":"Shen","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.molimm.2025.08.024_bib25","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.18632\/oncotarget.14815","article-title":"DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.molimm.2025.08.024_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14715\/cmb\/2019.66.1.7","article-title":"Antitumor mechanism of MAP30 in bladder cancer T24 cells, and its potential toxic effects in mice","volume":"66","author":"Shi","year":"2020","journal-title":"Cell. Mol. Biol. (Noisyle. Gd. Fr. )"},{"key":"10.1016\/j.molimm.2025.08.024_bib27","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.molimm.2025.08.024_bib28","article-title":"The role of the transcription factor EGR1 in cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molimm.2025.08.024_bib29","first-page":"61","article-title":"Cathepsin l activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.molimm.2025.08.024_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41598-020-79869-9","article-title":"CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1","volume":"11","author":"Wong","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2025.08.024_bib31","first-page":"1515","article-title":"[Hsa-miR-148a-3p promotes malignant behavior of breast cancer cells by downregulating DUSP1]","volume":"43","author":"Xu","year":"2023","journal-title":"Nan Fang. yi ke da xue xue bao = J. South. Med. Univ."},{"key":"10.1016\/j.molimm.2025.08.024_bib32","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1111\/jcmm.14597","article-title":"EGR1 interacts with DNMT3L to inhibit the transcription of miR-195 and plays an anti-apoptotic role in the development of gastric cancer","volume":"23","author":"Yang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.molimm.2025.08.024_bib33","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1089\/dna.2020.5469","article-title":"MAP30 inhibits bladder cancer cell migration and invasion in vitro through suppressing akt pathway and the Epithelial\/Mesenchymal transition process","volume":"39","author":"Zhang","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.molimm.2025.08.024_bib34","doi-asserted-by":"crossref","first-page":"7191","DOI":"10.1158\/0008-5472.CAN-14-1379","article-title":"DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma","volume":"74","author":"Zhang","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2025.08.024_bib35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.sjbs.2017.09.015","article-title":"DUSP1 is involved in the progression of small cell carcinoma of the prostate","volume":"25","author":"Zhang","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.molimm.2025.08.024_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153666","article-title":"Low EGR1 expression predicts poor prognosis in clear cell renal cell carcinoma","volume":"228","author":"Zhang","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.molimm.2025.08.024_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13258-021-01064-5","article-title":"EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression","volume":"43","author":"Zhao","year":"2021","journal-title":"Genes Genom."},{"key":"10.1016\/j.molimm.2025.08.024_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2174\/1574892818666221103114649","article-title":"Ribosome-inactivating protein MAP30 isolated from momordica charantia L. Induces apoptosis in hepatocellular carcinoma cells","volume":"19","author":"Zhou","year":"2024","journal-title":"Recent Pat. Anti-Cancer Drug Discov."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:24:20Z","timestamp":1762248260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025002184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"alternative-id":["S0161589025002184"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.08.024","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MAP30 inhibits proliferation and metastasis of bladder cancer by increasing EGR1 expression and promoting the transcriptional activation of DUSP1","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}